Coral Reef Microbes Harbor More Drug Potential Than the Entire Open Ocean - and They're Disappearing

Inside the tissues and gastric cavities of reef-building corals live communities of bacteria and archaea that science has barely begun to catalog. A study published in Nature by researchers at ETH Zurich and EPFL has now mapped those communities at a scale that reframes what marine loss actually means for medicine and biotechnology.

The numbers tell the story. From more than 800 coral samples collected during a ten-year-old Pacific expedition by the research vessel Tara, the team reconstructed the genomes of 645 distinct microbial species. Of those, more than 99 percent had no existing genomic data - they were, in the formal scientific sense, unknown to science before this study.

A Microbiome Structured Around Competition

Coral reefs cover less than one percent of the ocean floor but support more than a third of all marine animal and plant species on Earth. That density creates intense competition. For a microorganism living on the surface of a coral host, the neighbors are close, the resources are contested, and survival favors any organism with a sophisticated chemical defense system.

That competitive pressure appears to have driven an unusual accumulation of biosynthetic gene clusters - the genetic blueprints for producing bioactive compounds - in reef-associated microbes. When the ETH Zurich team, led by Shinichi Sunagawa and Jorn Piel, compared their coral microbiome data against open-ocean water samples from the same Tara dataset, the contrast was stark. The coral-associated organisms harbored more biosynthetic potential per genome than the entire open-ocean microbiome.

"We found more potential for the production of natural products in the genomes of coral reef microorganisms than we had previously found across the entire open ocean," Sunagawa said. The implication is that every coral species - potentially every coral individual - hosts a chemically distinct microbial community with its own portfolio of undiscovered compounds.

Specificity That Mirrors Human Gut Biology

The geographic analysis produced another notable finding: these reef microbes are not distributed broadly across the Pacific. They are reef-restricted, and within reefs they tend to associate with particular coral genera, with little overlap between different hosts. The pattern resembles the specificity of the human gut microbiome - each host maintains a community shaped by its own biology, and that community does not simply transfer to a different host.

This specificity has a direct consequence for loss estimates. When a coral species bleaches and dies, it does not merely reduce the total number of corals in the sea. It eliminates a particular microbial community that likely exists nowhere else - one whose members may have spent millions of years evolving the compounds they produce. Fifty percent of the world's coral populations have disappeared since the 1950s, largely due to rising ocean temperatures. The microbial loss embedded in that statistic has not previously been quantified.

The Sample Represents a Fraction

The study examined corals from three genera. The researchers note that several hundred coral genera are currently recognized, comprising several thousand species. They have not been surveyed. Neither have the microbiomes of sponges, molluscs, algae, and other species-rich reef organisms, each of which may harbor comparably rich microbial communities.

"In the latest study, we examined corals from just three genera. In total, however, there are several hundred known genera, comprising several thousand species," Sunagawa said. The current dataset, however significant, represents a small window into a largely uncatalogued biological system.

Piel, who leads the chemical ecology group at ETH Zurich and co-led the study, described the findings as evidence of "enormous potential for biotechnological and medical applications." The compounds natural products researchers typically target - antibiotics, antivirals, anti-cancer agents - are disproportionately drawn from marine microorganisms. The coral reef microbiome, if it can be characterized before it disappears, may represent one of the largest untapped reservoirs of such compounds.

Time Pressure and What It Means Practically

The researchers are explicit about urgency. "We are under time pressure to tap into and protect this potential," Sunagawa said. That framing has two practical dimensions. One is scientific: the window for sampling and cataloging these organisms is narrowing as reef degradation accelerates. The other is conservational: biodiversity protection arguments for coral reefs have historically emphasized visible species - fish, invertebrates, corals themselves. This study adds a microbial layer to those arguments.

One limitation worth noting: the study used metagenomic sequencing and computational genome reconstruction rather than direct isolation and culture of these organisms. This means the biosynthetic gene clusters identified are predicted on the basis of genome sequence - most have not yet been linked to specific compounds in the laboratory. The actual chemical output of these genetic programs remains largely unknown. Translating the genetic potential identified here into actual drugs would require years of additional work including culture, isolation, structural analysis, and preclinical testing.

The study was conducted by ETH Zurich research groups led by Sunagawa and Piel, in cooperation with Lucas Paoli from EPFL and the Tara Pacific Consortium, the international research partnership that organized and executed the original Pacific sampling expedition.